Commitments and Contingencies (Details) (Abbott Biotherapeutics Corp [Member], USD $)
|
12 Months Ended |
---|---|
Dec. 31, 2013
|
|
Phase 1 Clinical Trial of a licensed product [Member]
|
|
Summary of milestone payment | |
Milestones payments | $ 750,000 |
Phase 2 Clinical Trial of a licensed product [Member]
|
|
Summary of milestone payment | |
Milestones payments | 750,000 |
Phase 3 Clinical Trial of a licensed product [Member]
|
|
Summary of milestone payment | |
Milestones payments | 1,500,000 |
Biological License Application filing with U.S. FDA [Member]
|
|
Summary of milestone payment | |
Milestones payments | 1,750,000 |
First Commercial Sale [Member]
|
|
Summary of milestone payment | |
Milestones payments | 1,500,000 |
After First Net Sales [Member]
|
|
Summary of milestone payment | |
Milestones payments | $ 1,500,000 |